Money Central Logo Money Central
1
H drugs [16]. Either in NICE evaluation or in the first application of the model used in this study [9] it is concluded that pregabalin is associated to more QALYs. However, given the divergences in clinical inputs, the magnitude of the gains is different. In a recent work [33], the authors also concluded for the cost-effectiveness of pregabalin vs. SSRIs/SNRIs in benzodiazepine-refractory outpati